| | | | | |
| €27,2450 | -0,22% | €240,47M | €18,98K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,1222 | +0,57% | €240,18M | €58,84K | |
TSI TCW Strategic Income Fund, Inc. | €3,7721 | +0,46% | €239,79M | €131,88K | |
PAII Pyrophyte Acquisition Corp. II | €8,8173 | +0,15% | €239,36M | €1,41K | |
| €12,2422 | +2,00% | €239,25M | €176,51K | |
YDES YD Bio Limited Ordinary Shares | €3,9864 | -0,22% | €239,25M | €7,95K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,6116 | +0,55% | €238,94M | €5,12K | |
RWAY Runway Growth Finance Corp. Common Stock | €5,6239 | -0,15% | €238,93M | €303,64K | |
JILL J.Jill, Inc. Common Stock | €16,9402 | -1,25% | €238,92M | €25,73K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,96875 | +3,67% | €238,49M | €829,77K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8430 | -0,05% | €238,43M | €132,60K | |
ACV Virtus Diversified Income & Convertible Fund | €22,7699 | +0,38% | €238,40M | €35,92K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7103 | +0,25% | €238,27M | €350,45K | |
| €1,2259 | +2,14% | €238,18M | €403,99K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5633 | -0,33% | €238,04M | €36,52K | |
